# LLM call: summary

- Turn: 2
- Sequence: 9
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 909
- Completion tokens: 368
- Total tokens: 1277
- Cost (USD): 0.000164

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1030: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn audit discovered undetected intruders entrenched for weeks in electricity transmission networks on three continents — including two Union operators — plus a major container port and water utility. In response, Brussels pushed a hardening pact for power, ports and water via Energy and Transport ministers, giving the EU cybersecurity agency operational lead for EU-wide automated patching, swarm-based detection, and cross-border response, with Rotterdam, Antwerp and the affected operators prioritized and procurement steered to European vendors. Defensive tooling emerged that closed a whole attack class with near-instant patching; transmission operators joined pilots while finance ministries, mayors stalled over cost-sharing, and gigafactory build faced court and siting protests over power and water. By December, cables and pilot sensors were underway but no system hardened end-to-end; U.S. lithography export pressure continued, resisted but unresolved, amid divided public relief and unease.


CURRENT NARRATIVE:
### The genome paper and the benefits office
Spring 2027 brought two shocks at once. A contested genome-model study claimed a non-expert with model help could reach a viable human-infecting design. Virologists quarrelled over methods and over publication itself, but health ministries read it as categorically different from past warnings.

At the same time, an ombudsman and then a court found an AI-supported system used in social insurance had systematically cut or flagged vulnerable claimants. The press framed it as a failure of the AI Act's high-risk safeguards — either the system should never have passed conformity assessment, or oversight had failed after deployment. The Commission chose the first reading, ordering an AI Office investigation with rights and data-protection bodies using existing oversight powers and backing suspension of the module and redress. No new regulatory measure was created for this response.

### Pushing hardening, starting bio detection
Brussels kept its single current priority on power, ports and water under the existing EU Critical Systems Hardening and Response Pact. The EU cybersecurity agency pushed automated patching and swarm-based detection into Rotterdam, Antwerp and the two breached transmission operators, funded by reprogrammed digital and connectivity money. Procurement steered to European vendors bought off sovereignty-minded states; mayors and finance ministers still haggled over who paid for municipal rollout.

The turn's one new measure is the Biological Resilience Shield, proposed through the health emergency and disease-control authorities: planned mandatory customer screening for gene-synthesis providers, sequencing-based wastewater and hospital detection pilots in five hub cities, and exercised response and stockpile readiness. As a high-cost cross-sectoral measure it requires at least two full turns to full effect, plus legislation, agency capacity and coordination with non-EU synthesis suppliers who are not automatically bound.

Delivery this turn was therefore preparatory and partial. Grid pilots expanded but no system was hardened end to end, and cost-sharing remained unsigned. For the Shield, only initial screening guidance and pilot scoping began; detection deployment was blocked in part by missing labs, reagents and trained staff with no pre-existing surge capacity, and closed replication of the genome claim started at small scale under existing research funds to settle methodology without spreading method. Gigafactory permitting inched forward in accelerated zones under the prior InvestAI commitment but stayed second in line for capital, with siting protests over power and water continuing and reprogrammed funds insufficient to advance energy, health and industrial build-outs at once. Public mood soured: relief on bio preparedness offset by anger over the benefits scandal.
```

## Raw response

```
Spring 2027 added two shocks: a contested genome-model study claiming AI could help a non-expert design a viable human pathogen, treated by health ministries as categorically new despite scientific dispute; and a court-confirmed finding that an AI welfare system systematically harmed vulnerable claimants, framed as an AI Act high-risk failure. The Commission ordered an AI Office investigation with rights bodies, suspension and redress, creating no new regulation.

Brussels kept its priority on hardening power, ports and water under the existing Pact, with the EU cybersecurity agency expanding automated patching and swarm detection to Rotterdam, Antwerp and breached transmission operators via reprogrammed funds and European vendors; no system hardened end-to-end and cost-sharing remained unsigned. The one new measure was the Biological Resilience Shield via health authorities — mandatory gene-synthesis screening, wastewater/hospital detection pilots in five hubs, stockpile readiness — requiring at least two turns, legislation, capacity, and non-EU supplier cooperation. Delivery was preparatory only: screening guidance, pilot scoping, and small closed replication of the genome claim, blocked by missing labs, reagents and staff. Gigafactory permitting inched forward in accelerated zones but stayed underfunded amid power/water protests. Public mood soured: bio-preparedness relief offset by benefits-scandal anger.
```
